Unknown

Dataset Information

0

The study on the treatment of Xuebijing injection (XBJ) in adults with severe or critical Corona Virus Disease 2019 and the inhibitory effect of XBJ against SARS-CoV-2.

ABSTRACT:

SUBMITTER: Ma Q 

PROVIDER: S-EPMC7347326 | biostudies-literature | 2020 Oct

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

The study on the treatment of Xuebijing injection (XBJ) in adults with severe or critical Corona Virus Disease 2019 and the inhibitory effect of XBJ against SARS-CoV-2.

Ma Qinhai Q   Qiu Minshan M   Zhou Hongxia H   Chen Jie J   Yang Xue X   Deng Zhenxuan Z   Chen Liping L   Zhou Jinchao J   Liao Yuping Y   Chen Qimin Q   Zheng Qianwei Q   Cai Lihua L   Shen Lihan L   Yang Zifeng Z  

Pharmacological research 20200709

Similar Datasets

Unknown Detecting Critical Functional Ingredients Group and Mechanism of Xuebijing Injection in Treating Sepsis.
| S-EPMC8687625 | biostudies-literature
Unknown The preventive effect of Xuebijing injection against cytokine storm for severe patients with COVID-19: A prospective randomized controlled trial.
| S-EPMC7847185 | biostudies-literature
Unknown Developing inhibitory peptides against SARS-CoV-2 envelope protein.
| S-EPMC10939250 | biostudies-literature
Unknown Flavonoids with inhibitory activity against SARS-CoV-2 3CLpro.
| S-EPMC7470085 | biostudies-literature
Unknown Computational perspectives revealed prospective vaccine candidates from five structural proteins of novel SARS corona virus 2019 (SARS-CoV-2).
| S-EPMC7531350 | biostudies-literature
Unknown Metabolomic Insights Into the Synergistic Effect of Biapenem in Combination With Xuebijing Injection Against Sepsis.
| S-EPMC7189733 | biostudies-literature
Unknown Duration of Replication-Competent Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Shedding Among Patients With Severe or Critical Coronavirus Disease 2019 (COVID-19).
| S-EPMC9213867 | biostudies-literature
Unknown Integrated Transcriptomic, Proteomic, and Network Pharmacology Analyses Unravel Key Therapeutic Mechanisms of Xuebijing Injection for Severe Acute Pancreatitis.
| S-EPMC12736240 | biostudies-literature
Unknown Potency of Fusion-Inhibitory Lipopeptides against SARS-CoV-2 Variants of Concern.
| S-EPMC9239157 | biostudies-literature
Unknown Insect protease inhibitors; promising inhibitory compounds against SARS-CoV-2 main protease.
| S-EPMC8755557 | biostudies-literature